noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Healthcare

Costar Technologies Inc.

Costar Technologies, Inc. Announces Date of 2022 Annual Meeting of[...]
Nunzia Pharmaceutical Corporation

Quarterly Disclosure Statement for Period Ending June 30,2022
CDC - Centers for Disease Control[...]

CDC streamlines COVID-19 guidance to help the public better protect[...]

Results

POINT Biopharma Global Inc.

07/01/2022 | Press release | Distributed by Public on 07/01/2022 14:18

Post-Effective Amendment to Registration Statement (Form POS AM)

Read this content

Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Sharing and Personal Tools

Please select the service you want to use:

Smartlinks | POINT Biopharma Global Inc. | News | Health | Local News | Company News | Public Companies | Biotechnology and Medical Research Companies | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago

Back